---
title: "Organovo (Nasdaq: ONVO) gives business update on its focus in developing treatments for inflammatory bowel disease."
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/233457407.md"
description: "In San Diego on March 27, 2025, Organovo Holdings, Inc. (Nasdaq: ONVO) shared a business update. The company, a clinical stage biotech firm, specializing in innovative treatments for inflammatory bowel disease (IBD), detailed their recent developments."
datetime: "2025-03-27T12:27:46.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/233457407.md)
  - [en](https://longbridge.com/en/news/233457407.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/233457407.md)
generator: "portal-rs"
---

# Organovo (Nasdaq: ONVO) gives business update on its focus in developing treatments for inflammatory bowel disease.

In San Diego on March 27, 2025, Organovo Holdings, Inc. (Nasdaq: ONVO) shared a business update. The company, a clinical stage biotech firm, specializing in innovative treatments for inflammatory bowel disease (IBD), detailed their recent developments.

### Related Stocks

- [ONVO.US](https://longbridge.com/en/quote/ONVO.US.md)

## Related News & Research

- [McKenzie Scott PC Announces Three San Diego Civil Rights Case Outcomes](https://longbridge.com/en/news/296538482.md)
- [Lexeo Therapeutics (NASDAQ:LXEO) CEO Sells 3,345 Shares of Stock](https://longbridge.com/en/news/296488408.md)
- [Baseball-MLB owners unanimously approve sale of San Diego Padres](https://longbridge.com/en/news/296137237.md)
- [Greenland Mines announces 1-for-50 reverse stock split effective Aug. 24](https://longbridge.com/en/news/296498837.md)
- [16:39 ETC.A.R.-backed group sues three California cities over efforts to limit housing near transit](https://longbridge.com/en/news/296534381.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**